Medical College of Wisconsin
CTSICores SearchResearch InformaticsREDCap

Juliana Alvarez Argote MD

Juliana Alvarez Argote MD profile photo picture

Assistant Professor

Institution: Medical College of Wisconsin
Department: Medicine
Division: Hematology and Oncology - Medicine
Program: Benign Hematology

Member of the Cancer Center
Member of the Cardiovascular Center

View Curriculum Vitae

Publications (19)

  • A mass spectrometry assay for detection of endogenous and lentiviral engineered hemoglobin in cultured cells and sickle cell disease mice. (Wang X, McKillop WM, Dlugi TA, Faber ML, Alvarez-Argote J, Chambers CB, Wilber A, Medin JA) J Gene Med 2024 Jan;26(1):e3567 PMID: 37455676 SCOPUS ID: 2-s2.0-85165380220 07/17/2023    
  • Immune checkpoint inhibitor-related adverse events: Real-world experience from a single veterans' affairs medical center. (Benz S, Sherman KA, Dasanu CA, Alvarez-Argote J) J Oncol Pharm Pract 2023 Jun 23:10781552231184178 PMID: 37350125 SCOPUS ID: 2-s2.0-85162616675 06/23/2023       1 Citation
  • Pathophysiological characterization of the Townes mouse model for sickle cell disease. (Alvarez-Argote J, Dlugi TA, Sundararajan T, Kleynerman A, Faber ML, McKillop WM, Medin JA) Transl Res 2023 Apr;254:77-91 PMID: 36323381 SCOPUS ID: 2-s2.0-85145313487 11/03/2022       4 Citations
  • Selecting appropriate therapy for hairy cell leukemia: current state and future prospects based on molecularly defined characterization. (Dasanu CA, Alvarez-Argote J, Goff CB) Expert Opin Pharmacother 2022 Aug;23(11):1239-1241 PMID: 35703589 SCOPUS ID: 2-s2.0-85131928853 06/16/2022    
  • Severe terminal ileitis induced by single-agent nivolumab administered every four weeks. (Dasanu CA, Plaxe SC, Gupta V, Popescu IM, Grover M, Alvarez-Argote J) J Oncol Pharm Pract 2020 Sep;26(6):1516-1519 PMID: 32028838 SCOPUS ID: 2-s2.0-85079465900 02/08/2020       3 Citations
  • Durvalumab in cancer medicine: a comprehensive review. (Alvarez-Argote J, Dasanu CA) Expert Opin Biol Ther 2019 Sep;19(9):927-935 PMID: 31272242 SCOPUS ID: 2-s2.0-85070812050 07/06/2019       36 Citations
  • Bevacizumab in refractory higher-grade and atypical meningioma: the current state of affairs. (Dasanu CA, Alvarez-Argote J, Limonadi FM, Codreanu I) Expert Opin Biol Ther 2019 Feb;19(2):99-104 PMID: 30556741 SCOPUS ID: 2-s2.0-85060297670 12/18/2018       15 Citations
  • Systemic therapy for relapsed/refractory meningioma: Is there potential for antiangiogenic agents? (Dasanu CA, Samara Y, Codreanu I, Limonadi FM, Hamid O, Alvarez-Argote J) J Oncol Pharm Pract 2019 Apr;25(3):638-647 PMID: 30253729 SCOPUS ID: 2-s2.0-85059350839 09/27/2018       12 Citations
  • Longitudinal thumbnail fissures due to erlotinib therapy for lung cancer. (Dasanu CA, Alvarez-Argote J, Lippman SM, Plaxe SC) J Oncol Pharm Pract 2018 Apr;24(3):229-231 PMID: 28436313 SCOPUS ID: 2-s2.0-85044117008 04/25/2017       2 Citations
  • ASXL1 mutations in myeloid neoplasms: pathogenetic considerations, impact on clinical outcomes and survival. (Alvarez Argote J, Dasanu CA) Curr Med Res Opin 2018 May;34(5):757-763 PMID: 28027687 SCOPUS ID: 2-s2.0-85045643814 12/29/2016       17 Citations
  • Cancer-related microangiopathic hemolytic anemia. (Choy B, Alvarez Argote J, Treml A) Transfusion 2016 Aug;56(8):1937 PMID: 27500918 SCOPUS ID: 2-s2.0-84982995109 08/09/2016       2 Citations
  • Autoimmune manifestations in patients with multiple myeloma and monoclonal gammopathy of undetermined significance. (Shimanovsky A, Alvarez Argote J, Murali S, Dasanu CA) BBA Clin 2016 Dec;6:12-8 PMID: 27331023 PMCID: PMC4900299 SCOPUS ID: 2-s2.0-84971321346 06/23/2016       38 Citations
  • Synchronous Tumors: Adenocarcinoma of the Esophagus and Clear Cell Renal Carcinoma. (Narra RK, Alvarez Argote J, Mesologites T, Dasanu CA) Conn Med 2015 Aug;79(7):401-4 PMID: 26411176 SCOPUS ID: 2-s2.0-84940653430 09/29/2015    
  • Autoimmune disorders in patients with T-cell lymphoma: a comprehensive review. (Van den Bergh M, Alvarez-Argote J, Panwala AH, Dasanu CA) Curr Med Res Opin 2015;31(10):1861-70 PMID: 26211818 SCOPUS ID: 2-s2.0-84942296898 07/28/2015       8 Citations
  • Autoimmune disorders in patients with hairy cell leukemia: are they more common than previously thought? (Dasanu CA, Van den Bergh M, Pepito D, Alvarez Argote J) Curr Med Res Opin 2015 Jan;31(1):17-23 PMID: 25265129 SCOPUS ID: 2-s2.0-84918822830 09/30/2014       13 Citations
  • Retroperitoneal fibrosis due to B-cell non-Hodgkin lymphoma: Responding to rituximab! (Alvarez Argote J, Bauer FA, Posteraro AF 3rd, Dasanu CA) J Oncol Pharm Pract 2016 Feb;22(1):179-85 PMID: 25013186 SCOPUS ID: 2-s2.0-84960839830 07/12/2014       4 Citations
  • CD5 negative mantle cell lymphoma: a different clinical entity? (Alvarez-Argote J, Bauer FA, Dasanu CA) Conn Med 2014 Apr;78(4):211-4 PMID: 24830117 SCOPUS ID: 2-s2.0-84901467611 05/17/2014       2 Citations
  • Decision boxes for clinicians to support evidence-based practice and shared decision making: the user experience. (Giguere A, Légaré F, Grad R, Pluye P, Haynes RB, Cauchon M, Rousseau F, Alvarez Argote J, Labrecque M) Implement Sci 2012 Aug 03;7:72 PMID: 22862935 PMCID: PMC3533695 SCOPUS ID: 2-s2.0-84864500281 08/07/2012       42 Citations
  • Survival to leukemia and lymphomas in children at a University Hospital in Cali, Colombia. (Diaz YV, Nichols-Vinueza DX, Alvarez-Argote J, Gutiérrez-Montealegre A, García LE, Bravo LE) J Pediatr Hematol Oncol 2011 Oct;33(7):e284-8 PMID: 21646918 SCOPUS ID: 2-s2.0-80053304694 06/08/2011    
    • Last update: 03/28/2024